SG Americas Securities’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
AC
SG Americas Securities's HRMY Position: Q2 2026 in Review
SG Americas Securities reduced its Harmony Biosciences (HRMY) stake by 56% in Q2 2026, selling an estimated $35.8M and leaving 882,720 shares worth $32.1M. The position accounts for 0.02% of the portfolio, ranked #464.
SG Americas Securities first reported a position in HRMY in Q3 2021 and has held it in 16 quarters since. The position peaked at $56.5M in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.
- SG Americas Securities held 882,720 shares of Harmony Biosciences worth $32.1M as of Q2 2026.
- SG Americas Securities sold 1,135,454 Harmony Biosciences shares in Q2 2026, an estimated $35.8M.
- Harmony Biosciences made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #464 holding.
- SG Americas Securities first reported a position in Harmony Biosciences in Q3 2021 and has held it in 16 quarters since.
- SG Americas Securities's Harmony Biosciences position peaked at $56.5M in Q1 2026.
- 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.